JPM Q3 Earnings: Key Metrics to Watch Against Estimates and Prior Year

What happened

JPMorgan Chase reported Q3 2026 results, and the Zacks article highlights the need to compare key metrics against Wall Street estimates and year-ago actuals. The DeepValue master report had rated JPM a WAIT with a conviction of 3.5, citing pressure from NII ex-Markets yield compression, expense growth, and card charge-offs. The Q3 report is a critical checkpoint to see if those trends reversed or persisted, especially whether NII ex-Markets held near the $95B annualized run-rate and overhead ratio stabilized around 53%. Without specific figures, the article provides no confirmation, and investors must independently assess the underlying quality of the results beyond headline EPS. The market will likely react to any deviation from the established benchmarks and management's forward commentary.

Implication

The investment thesis remains contingent on core earnings stability and cost discipline; until JPM demonstrates improvement, the premium valuation at 14x P/E and 2.3x P/B is not justified, and the WAIT stance remains appropriate.

Thesis delta

The thesis is unchanged because the news lacks detailed metrics; however, Q3 results serve as a trigger for re-evaluation. If the company shows deterioration in NII ex-Markets or rising expenses, we would lower the conviction and potentially exit positions.